Stocks · Coverage Archive

$EYPT

4.77 ▼ 67.69%

Every Regards of Wallstreet article on $EYPT, newest first — 1 story and counting.

Followed tickers pin their next report date and latest coverage to the homepage and the earnings calendar.

  1. 2026-08-17 · 7 min read

    Why Is EyePoint (EYPT) Stock Down Today? A Trial Miss With An Asterisk

    EyePoint shares were down about 69% intraday Monday after DURAVYU missed the primary endpoint of the LUGANO Phase 3 wet AMD trial, though a post-hoc analysis found non-inferiority.

New to options? See our plain-English strategy playbook →

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Saturday brief.

Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.